Fenocare 200 Tablet contains Fenofibrate 200 mg, a peroxisome proliferator-activated receptor (PPAR) alpha agonist used for the management of high cholesterol and triglyceride levels. It helps reduce LDL cholesterol, total cholesterol, and triglycerides, while slightly increasing HDL cholesterol, supporting overall cardiovascular health.
Belonging to the cardiology and lipid management segment, Fenocare 200 Tablet is widely prescribed for patients with hyperlipidemia, mixed dyslipidemia, and cardiovascular risk factors. Its efficacy ensures strong patient adherence and repeat prescriptions.
Fenofibrate works by activating enzymes that break down lipids in the blood, improving lipid profiles and reducing the risk of heart disease and atherosclerosis.
For PCD pharma franchise partners, distributors, exporters, and third-party manufacturing clients, Fenocare 200 Tablet offers a profitable B2B opportunity, with stable demand in hospitals, clinics, and retail pharmacies across India.